🇨🇦 Paroxetine CR for Major Depressive Episode in Canada

Paroxetine CR for Major Depressive Episode (Paroxetine CR for Major Depressive Episode) regulatory status in Canada.

Marketing authorisation

Paroxetine CR for Major Depressive Episode in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Paroxetine CR for Major Depressive Episode approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Paroxetine CR for Major Depressive Episode in Canada?

New York State Psychiatric Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.